{"schema_version":"secwatch.filing_event.v1","accession":"0001801170-23-000041","form_type":"8-K","ticker":"CLOV","cik":"0001801170","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","filed_at":"2023-06-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.655867+00:00","generated_at":"2026-06-14T04:08:57.019753+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Clover Health shareholders elect directors, approve say-on-pay and auditor ratification at 2023 annual meeting","bullets":["Directors Demetrios L. Kouzoukas and Andrew Toy elected with ~937M and ~939M votes for, respectively; 123M broker non-votes.","Say-on-pay proposal approved: 938.8M for, 15.4M against, 1.4M abstain; broker non-votes 123M.","Ratification of Ernst & Young as FY2023 auditor passed: 1.07B for, 3.3M against, 1.7M abstain.","All three proposals passed with strong majority support; no contested matters."],"urls":{"canonical":"https://secwatch.observer/filing/0001801170-23-000041","json":"https://secwatch.observer/filing/0001801170-23-000041.json","markdown":"https://secwatch.observer/filing/0001801170-23-000041.md","text":"https://secwatch.observer/filing/0001801170-23-000041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1801170/000180117023000041/0001801170-23-000041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1801170/000180117023000041/clov-20230607.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T04:08:57.019753+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1f1655946cd51933b1e5d7faeba5bacc625d2bf2","claim":"CLOVER HEALTH INVESTMENTS, CORP. /DE shareholders approved Non-binding advisory vote to approve the compensation of the Company's Named Executive Officers for 2022 at the 2023-06-07 meeting.","evidence_excerpt":"Non-binding advisory vote to approve the compensation of the Company's Named Executive Officers for 2022: The stockholders vote to approve, on a non-binding advisory basis, the compensation of the Company's Named Executive Officers for 2022. The results of the vote were as follows: For Against Abstain Broker Non-Votes 938,847,123 15,400,898 1,440,947 123,427,586","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117023000041/0001801170-23-000041-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-07"}],"fact_type":"shareholder_vote"},{"claim_id":"58e7086e894aedb0f01114ce0145a337f6e91d88","claim":"CLOVER HEALTH INVESTMENTS, CORP. /DE shareholders approved Election of 2 Class II directors at the 2023-06-07 meeting.","evidence_excerpt":"The results of the election were as follows: Nominee For Withheld Broker Non-Votes Demetrios L Kouzoukas 937,464,810 18,224,158 123,427,586 Andrew Toy 939,487,709 16,201,259 123,427,586","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117023000041/0001801170-23-000041-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-07"}],"fact_type":"shareholder_vote"},{"claim_id":"f52b74aa55c01536c83c856a82b0fa6d6c93725c","claim":"CLOVER HEALTH INVESTMENTS, CORP. /DE shareholders approved Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-07 meeting.","evidence_excerpt":"Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023. The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. The results of the vote were as follows: For Against Abstain 1,074,118,616 3,280,363 1,717,575","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117023000041/0001801170-23-000041-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-07"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}